These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3914315)

  • 1. Urodynamic biofeedback treatment of urinary incontinence in children with myelomeningocele.
    Killam PE; Jeffries JS; Varni JW
    Biofeedback Self Regul; 1985 Jun; 10(2):161-71. PubMed ID: 3914315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of biofeedback in treatment of fecal incontinence in patients with meningomyelocele.
    Wald A
    Pediatrics; 1981 Jul; 68(1):45-9. PubMed ID: 7243508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofeedback treatment of fecal incontinence in patients with myelomeningocele.
    Whitehead WE; Parker LH; Masek BJ; Cataldo MF; Freeman JM
    Dev Med Child Neurol; 1981 Jun; 23(3):313-22. PubMed ID: 7250540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofeedback training for patients with myelomeningocele and fecal incontinence.
    Loening-Baucke V; Desch L; Wolraich M
    Dev Med Child Neurol; 1988 Dec; 30(6):781-90. PubMed ID: 3234607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofeedback for neurogenic fecal incontinence: rectal sensation is a determinant of outcome.
    Wald A
    J Pediatr Gastroenterol Nutr; 1983 May; 2(2):302-6. PubMed ID: 6875754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of fecal incontinence in children with spina bifida: comparison of biofeedback and behavior modification.
    Whitehead WE; Parker L; Bosmajian L; Morrill-Corbin ED; Middaugh S; Garwood M; Cataldo MF; Freeman J
    Arch Phys Med Rehabil; 1986 Apr; 67(4):218-24. PubMed ID: 3964054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of faecal incontinence in children with spina bifida by biofeedback and behavioural modification.
    Pappo I; Meyer S; Winter S; Nissan S
    Z Kinderchir; 1988 Dec; 43 Suppl 2():36-7. PubMed ID: 3213249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofeedback training for detrusor overactivity in children.
    Yamanishi T; Yasuda K; Murayama N; Sakakibara R; Uchiyama T; Ito H
    J Urol; 2000 Nov; 164(5):1686-90. PubMed ID: 11025748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.
    Kajbafzadeh A; Mahboubi AH; Payabvash S
    BJU Int; 2009 May; 103(9):1248-54. PubMed ID: 19154454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele.
    Kajbafzadeh AM; Moosavi S; Tajik P; Arshadi H; Payabvash S; Salmasi AH; Akbari HR; Nejat F
    Urology; 2006 Nov; 68(5):1091-6; discussion 1096-7. PubMed ID: 17113899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofeedback therapy for managing bowel incontinence caused by meningomyelocele.
    Richardson K; Campbell MA; Brown MR; Masiulis B; Liptak GS
    MCN Am J Matern Child Nurs; 1985; 10(6):388-92. PubMed ID: 3932809
    [No Abstract]   [Full Text] [Related]  

  • 12. Urodynamic biofeedback: a new therapeutic approach for childhood incontinence/infection (vesical voluntary sphincter dyssynergia).
    Sugar EC; Firlit CF
    J Urol; 1982 Dec; 128(6):1253-8. PubMed ID: 7154180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urological consequences of incomplete cord lesions in patients with myelomeningocele.
    Keshtgar AS; Rickwood AM
    Br J Urol; 1998 Aug; 82(2):258-60. PubMed ID: 9722763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of initial urodynamic pattern on urinary continence in patients with myelomeningocele.
    Kessler TM; Lackner J; Kiss G; Rehder P; Madersbacher H
    Neurourol Urodyn; 2006; 25(4):361-7. PubMed ID: 16721816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of neurogenic bladder dysfunction secondary to myelomeningocele.
    Castro-Gago M; Novo I; Cimadevila A; Peña J; Rodriguez-Núñez A; Marqués'-Queimadelos A
    Eur J Pediatr; 1990 Nov; 150(1):62-5. PubMed ID: 2079080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary and Fecal Continence in 5-Year-Old Patients Who Underwent in utero Myelomeningocele Repair: A Prospective Study.
    Macedo A; Cavalheiro S; Moron A; Lobountchenko T; Dini FS; Ottoni SL; Garrone G; Ligori R; Leal da Cruz M
    Fetal Diagn Ther; 2019; 46(5):319-322. PubMed ID: 30884481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified biofeedback program for children with detrusor-sphincter dyssynergia: 5-year experience.
    Chin-Peuckert L; Salle JL
    J Urol; 2001 Oct; 166(4):1470-5. PubMed ID: 11547115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stooling problems in patients with myelomeningocele.
    Younoszai MK
    South Med J; 1992 Jul; 85(7):718-24. PubMed ID: 1631686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of myelomeningocele.
    Kaplan WE
    Urol Clin North Am; 1985 Feb; 12(1):93-101. PubMed ID: 3883627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.